Assessment of serum (1→3)-β-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis

Nathan P. Wiederhold; Laura K. Najvar; Ana C. Vallor; William R. Kirkpatrick; Rosie Bocanegra; Destiny Molina; Marcos Olivo; John R. Graybill; Thomas F. Patterson

doi:10.1128/AAC.01425-07

Assessment of serum (1→3)-β-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis

Nathan P. Wiederhold, Laura K. Najvar, Ana C. Vallor, William R. Kirkpatrick, Rosie Bocanegra, Destiny Molina, Marcos Olivo, John R. Graybill, Thomas F. Patterson

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Serum (1→3)-β-D-glucan concentrations were serially measured in the presence and absence of antifungal therapy in a murine model of invasive pulmonary aspergillosis. Serum (1→3)-ß-D-glucan was detected early during the course of infection, and reductions in this biomarker were associated with improved survival in animals treated with antifungal agents.

Original language	English (US)
Pages (from-to)	1176-1178
Number of pages	3
Journal	Antimicrobial agents and chemotherapy
Volume	52
Issue number	3
DOIs	https://doi.org/10.1128/AAC.01425-07
State	Published - Mar 2008

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/AAC.01425-07

Cite this

Wiederhold, N. P., Najvar, L. K., Vallor, A. C., Kirkpatrick, W. R., Bocanegra, R., Molina, D., Olivo, M., Graybill, J. R., & Patterson, T. F. (2008). Assessment of serum (1→3)-β-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis. Antimicrobial agents and chemotherapy, 52(3), 1176-1178. https://doi.org/10.1128/AAC.01425-07

Assessment of serum (1→3)-β-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis. / Wiederhold, Nathan P.; Najvar, Laura K.; Vallor, Ana C.; Kirkpatrick, William R.; Bocanegra, Rosie; Molina, Destiny; Olivo, Marcos; Graybill, John R.; Patterson, Thomas F.

In: Antimicrobial agents and chemotherapy, Vol. 52, No. 3, 03.2008, p. 1176-1178.

Research output: Contribution to journal › Article › peer-review

Wiederhold, NP, Najvar, LK, Vallor, AC, Kirkpatrick, WR, Bocanegra, R, Molina, D, Olivo, M, Graybill, JR & Patterson, TF 2008, 'Assessment of serum (1→3)-β-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis', Antimicrobial agents and chemotherapy, vol. 52, no. 3, pp. 1176-1178. https://doi.org/10.1128/AAC.01425-07

Wiederhold, Nathan P. ; Najvar, Laura K. ; Vallor, Ana C. ; Kirkpatrick, William R. ; Bocanegra, Rosie ; Molina, Destiny ; Olivo, Marcos ; Graybill, John R. ; Patterson, Thomas F. / Assessment of serum (1→3)-β-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis. In: Antimicrobial agents and chemotherapy. 2008 ; Vol. 52, No. 3. pp. 1176-1178.

@article{d328dee29e184f11848db390a5146da3,

title = "Assessment of serum (1→3)-β-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis",

abstract = "Serum (1→3)-β-D-glucan concentrations were serially measured in the presence and absence of antifungal therapy in a murine model of invasive pulmonary aspergillosis. Serum (1→3)-{\ss}-D-glucan was detected early during the course of infection, and reductions in this biomarker were associated with improved survival in animals treated with antifungal agents.",

author = "Wiederhold, {Nathan P.} and Najvar, {Laura K.} and Vallor, {Ana C.} and Kirkpatrick, {William R.} and Rosie Bocanegra and Destiny Molina and Marcos Olivo and Graybill, {John R.} and Patterson, {Thomas F.}",

year = "2008",

month = mar,

doi = "10.1128/AAC.01425-07",

language = "English (US)",

volume = "52",

pages = "1176--1178",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "3",

}

TY - JOUR

T1 - Assessment of serum (1→3)-β-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis

AU - Wiederhold, Nathan P.

AU - Najvar, Laura K.

AU - Vallor, Ana C.

AU - Kirkpatrick, William R.

AU - Bocanegra, Rosie

AU - Molina, Destiny

AU - Olivo, Marcos

AU - Graybill, John R.

AU - Patterson, Thomas F.

PY - 2008/3

Y1 - 2008/3

N2 - Serum (1→3)-β-D-glucan concentrations were serially measured in the presence and absence of antifungal therapy in a murine model of invasive pulmonary aspergillosis. Serum (1→3)-ß-D-glucan was detected early during the course of infection, and reductions in this biomarker were associated with improved survival in animals treated with antifungal agents.

AB - Serum (1→3)-β-D-glucan concentrations were serially measured in the presence and absence of antifungal therapy in a murine model of invasive pulmonary aspergillosis. Serum (1→3)-ß-D-glucan was detected early during the course of infection, and reductions in this biomarker were associated with improved survival in animals treated with antifungal agents.

UR - http://www.scopus.com/inward/record.url?scp=40549143047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40549143047&partnerID=8YFLogxK

U2 - 10.1128/AAC.01425-07

DO - 10.1128/AAC.01425-07

M3 - Article

C2 - 18160526

AN - SCOPUS:40549143047

VL - 52

SP - 1176

EP - 1178

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 3

ER -

Assessment of serum (1→3)-β-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this